Yoshitsu’s Hong Kong subsidiary Tokyo Lifestyle entered into a $2.75M loan agreement on July 10 with a wholly-owned subsidiary of Tasly Healthcare, a pharmaceutical conglomerate based in China, to support TLS’s future growth and development. TLS has secured $2.75M in funding from Best Life Technology, a subsidiary of Tasly, with the term of the loan running from July 15, 2024 to July 14, 2025. The loan is guaranteed by Yoshitsu and Shenzhen Qingzhi Liangpin Network Technology, a wholly-owned subsidiary of TLS. Previously on October 18, the company entered into a strategic cooperation agreement with Tasly to cooperate on matters related to investment in research and development and sales of health products globally. The company expects that its collaboration with Tasly will help solidify and grow its presence in the health product sector.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TKLF: